BAM
MBOT icon

Blueshift Asset Management’s Microbot Medical MBOT Stock Holding History

Blueshift Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,841
Closed -$81K – 882
2022
Q1 		$81K Buy
+12,841
New +$75.2K 0.01% 774

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Blueshift Asset Management's MBOT Position: Q2 2022 in Review

Blueshift Asset Management sold out of Microbot Medical (MBOT) in Q2 2022, closing a stake of 12,841 shares — an estimated $81K sold.

Blueshift Asset Management first reported a position in MBOT in Q1 2022 and held it in 1 quarter. The position peaked at $81K in Q1 2022. 25 funds tracked by Wall St. Rank hold MBOT as of Q2 2022.

  • Blueshift Asset Management reported no remaining Microbot Medical position as of Q2 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 12,841 Microbot Medical shares in Q2 2022, an estimated $81K.
  • Blueshift Asset Management first reported a position in Microbot Medical in Q1 2022 and held it in 1 quarter.
  • Blueshift Asset Management's Microbot Medical position peaked at $81K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.